AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ROCKVILLE, Md. -- Lester Crawford resigned Friday as commissioner of the Food and Drug Administration, ending a FDA career that included separate stints as acting FDA commissioner and two months as a confirmed commissioner.
One day following Crawford's announcement, the White House issued a release naming Andrew von Eschenbach, currently director of the National Cancer Institute, as acting FDA commissioner. Von Eschenbach, who intends to remain in his role at the Cancer Institute, said it was too soon to speculate whether he would be nominated for the FDA commissioner post on a permanent …